Bamipine

{{Short description|Chemical compound}}

{{Drugbox

| verifiedrevid = 437205596

| IUPAC_name = N-benzyl-1-methyl-N-phenyl-piperidin-4-amine

| image = Bamipine.svg

| tradename = Soventol

| Drugs.com = {{drugs.com|international|bamipine}}

| routes_of_administration = Oral?, topical

| CAS_number_Ref = {{cascite|correct|??}}

| CAS_number = 4945-47-5

| ATC_prefix = D04

| ATC_suffix = AA15

| ATC_supplemental = {{ATC|R06|AX01}}

| PubChem = 72075

| DrugBank_Ref = {{drugbankcite|correct|drugbank}}

| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}

| ChemSpiderID = 65061

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = Y6BHZ28O92

| KEGG_Ref = {{keggcite|correct|kegg}}

| KEGG = D07197

| ChEMBL_Ref = {{ebicite|correct|EBI}}

| ChEMBL = 520400

| C=19 | H=24 | N=2

| smiles = N(c1ccccc1)(Cc2ccccc2)C3CCN(C)CC3

| StdInChI_Ref = {{stdinchicite|correct|chemspider}}

| StdInChI = 1S/C19H24N2/c1-20-14-12-19(13-15-20)21(18-10-6-3-7-11-18)16-17-8-4-2-5-9-17/h2-11,19H,12-16H2,1H3

| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}

| StdInChIKey = VZSXTYKGYWISGQ-UHFFFAOYSA-N

}}

Bamipine (trade name Soventol){{Cite book |last=Publishing |first=William Andrew |url=https://books.google.com/books?id=_J2ti4EkYpkC&pg=PA523 |title=Pharmaceutical Manufacturing Encyclopedia, 3rd Edition |date=2013-10-22 |publisher=Elsevier |isbn=978-0-8155-1856-3 |page=523 |language=en}} is a pharmaceutical drug acting as an H₁ antihistamine with anticholinergic properties.{{cite book | vauthors = Vardanyan RS | chapter = Chapter 5: 4-Substituted and 1,4-Disubstituted Piperidines |title=Piperidine-based drug discovery |date=2017 |location=Amsterdam, Netherlands |isbn=978-0-12-813428-3 |page=191 | chapter-url=https://books.google.com/books?id=szxHDgAAQBAJ&dq=Bamipine&pg=PA191}} It is used as an antipruritic ointment.{{cite patent | country = WO | number = 0236163 |title = Pharmaceutical compositions containing tiotropium salts and antihistamines and their use |inventor = Pairet M, Pieper MP, Meade CJ, Schmelzer C | assign1 = Boehringer Ingelheim |pubdate = 10 May 2002 }} No oral use is known.{{drugs.com|international|bamipine}}: Bamipine.